In light of genetic analysis, a study identified that a genetic variation in POMC and NR3C1 might contribute to the pathophysiology of subgroups of patients with ME/CFS [184]. This evidence concerns the gene NR3C1 and myalgic encephalomeyelitis/chronic fatigue syndrome.